Back to search
FDAFDA · Food and drugs·Recall number D-0246-2025

Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use Only, Manufactured by Padagis, Yeruham, Israel, NDC: 45802-0134-30

Published March 5, 2025 · Recall initiated: February 6, 2025

Summary

FDA records drug Class II recall D-0246-2025, published March 5, 2025 and initiated February 6, 2025. Recalling firm: Padagis US LLC; Status: Completed; Reported quantity: 4944 cartons; Lot: Lot # 193109; Exp. 07/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Padagis US LLC
Distributor
Nationwide in the USA
Lot
Lot # 193109; Exp. 07/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use Only, Manufactured by Padagis, Yeruham, Israel, NDC: 45802-0134-30 recalled?

Yes. FDA published recall D-0246-2025 on March 5, 2025. Reported hazard: Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter